Mode
Text Size
Log in / Sign up
N/A N=36 Randomized Treatment

Incidence of Sleep-disordered Breathing and Upper Airway Collapsibility in Postpartum Patients and Its Intervention

Sleep Disordered Breathing · Upper Airway Collapsibility · Upper Airway Obstruction

Enrolled (actual)
36
Serious AEs
Results posted
Dec 2017
Primary outcome: Primary: Apnea-hypopnea Index (AHI), Defined as the Number of Apneas and Hypopneas Per Hour of Sleep — 4.5; 7.7 Apneas and hypopneas per hour of sleep

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
elevated body position (Procedure); supine body position (Procedure)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
Massachusetts General Hospital
Primary completion
Oct 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Apnea-hypopnea Index (AHI), Defined as the Number of Apneas and Hypopneas Per Hour of Sleep
4.5; 7.7
SECONDARY
Minimum Upper Airway Cross-sectional Area: to Elucidate the Anatomical and Physiological Risk Factors That Contribute to the Upper Airway Obstruction in Post-partum Patients
1.54; 1.35; 1.46

Summary

The investigators hypothesized that sleeping in a 45 degrees elevated body position decreases the likelihood of upper airway vulnerability to collapse early after delivery. Furthermore, the investigators want to elucidate the anatomical and physiological risk factors that contribute in the upper airway obstruction in post-partum patients.

Eligibility Criteria

Inclusion Criteria

  • Postpartum mothers within 48 hours of delivery in a major academic teaching hospital.
  • Age over 18 years.
  • Admitted to the Massachusetts General Hospital OB service for the delivery.
  • Interventions will be randomly assigned to the patients enrolled in this study

Exclusion Criteria

  • Age under 18 years.
  • History of pre-existing pulmonary and cardiac diseases, including bronchial asthma, cystic fibrosis, chronic obstructive lung disease, neck and chest tumors (thyroid, mediastinal, etc.), irradiation to the neck and/or chest, and congenital airway deformities, other critically-ill conditions.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01719224). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search